Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH),atypical hemolytic uremic ...

Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome. According to ...

Efzimfotase alfa is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Hypophosphatasia. According to GlobalData, Phase III drugs for Hypophosphatasia have a 100% ...

(RTTNews) - Wednesday, Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent with the pan-Canadian Pharmaceutical Alliance for Koselugo for the ...

NYU Langone Health acknowledges United Therapeutics for the UKidney and financial support provided for xenotransplantation research initiatives, as well as the support of Alexion Pharmaceuticals ...

Saadia Group, which acquired the department store during a bankruptcy auction four years ago and ran it until early this year, in 2022 had replaced the familiar, idiosyncratic logo with a ...

"As a founding member of the BeginNGS Consortium, Alexion is encouraged by these Phase 2 results and remains committed to advancing health equity by helping improve diagnostics for families ...

While the UN Global Compact logo is for use by our initiative only, we encourage participants in good standing to use the Endorser "We Support" logo. It can be used, for example, on websites and ...

It has only been a month since AstraZeneca's $39 billion takeover of Alexion was completed, but the new combination has already had a setback. Alexion has dropped development of its Ultomiris drug ...